About: Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.81 (-1.03%)
FLNA NASDAQ Filana Therapeutics, Inc.
Filana Therapeutics, Inc. share price
FLNA price activity
Último preço
$ 0,810
Variação (24h)
-0,01 USD (-1,03%)
Volume
258.78K
Volume (média 4 sem.)
-
Abertura
$ 0,80
Variação do dia
$ 0,78 - $ 0,81
Fechamento anterior
$ 0,82
Último negócio
08 Oct, 6:22 pm GMT+0
Atrasado
08 Oct, 6:22 pm GMT+0
FLNA price performance
Atrasado
08 Oct, 6:22 pm GMT+0
quote.marketSignals